Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial

结直肠腺瘤 安慰剂 结肠镜检查 随机对照试验 胃肠病学 医学 人口 息肉切除术 腺瘤 多中心试验 内科学 结直肠癌 外科 多中心研究 病理 癌症 替代医学 环境卫生
作者
Mingxin Ni,Ye Zhang,Zhenzhen Sun,Qingde Zhou,Jun Xiao,Beiping Zhang,Lin Jiang,Bo Gong,Fengbin Liu,Fandong Meng,Gangtie Zheng,Yan Wang,Li-Mei Gu,Liu Li,Weixing Shen,Yugen Chen,Yanmei Liu,Ling Li,Tao Ling,Haibo Cheng
出处
期刊:Phytomedicine [Elsevier]
卷期号:: 155496-155496
标识
DOI:10.1016/j.phymed.2024.155496
摘要

Colorectal adenoma is benign glandular tumor of colon, the precursor of colorectal cancer. But no pharmaceutical medication is currently available to treat and prevent adenomas. To evaluate efficacy of Shenbai Granules, an herbal medicine formula, in reducing the recurrence of adenomas. This multicenter, randomized, double-blind, placebo-controlled clinical trial was conducted by eight hospitals in China. Patients who had received complete polypectomy and were diagnosed with adenomas within the recent 6 months were randomly assigned (1:1) to receive either Shenbai granules or placebo twice a day for 6 months. An annual colonoscopy was performed during the 2-year follow-up period. The primary outcome was the proportion of patients with at least one adenoma detected in the modified intention-to-treat (mITT) population during follow-up for 2 years. The secondary outcomes were the proportion of patients with sessile serrated lesions and other specified polypoid lesions. The data were analyzed using logistic regression. Among 400 randomized patients, 336 were included in the mITT population. We found significant differences between treatment and placebo groups in the proportion of patients with at least one recurrent adenoma (42.5% vs. 58.6%; OR, 0.52; 95% CI, 0.34–0.81; P = 0.003) and sessile serrated lesion (1.8% vs. 8.3%; OR, 0.20; 95% CI, 0.06–0.72; P = 0.01). There was no significant difference in the proportion of patients developing polypoid lesions (70.7% vs. 77.5%; OR, 1.43; 95% CI, 0.88–2.34; P = 0.15) or high-risk adenomas (9.0% vs. 13.6%; OR, 0.63; 95% CI, 0.32–1.25; P = 0.18). Shenbai Granules significantly reduced the recurrence of adenomas, indicating that they could be an effective option for adenomas. Future studies should investigate its effects in larger patient populations and explore its mechanism of action to provide more comprehensive evidence for the use of Shenbai Granules in adenoma treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Simone完成签到,获得积分10
1秒前
1秒前
1秒前
4秒前
受伤飞丹发布了新的文献求助10
4秒前
6秒前
7秒前
9秒前
9秒前
niwe发布了新的文献求助20
10秒前
小二郎应助靓丽的如南采纳,获得10
13秒前
wsff完成签到,获得积分10
17秒前
努力努力123完成签到,获得积分10
17秒前
18秒前
oleskarabach发布了新的文献求助10
18秒前
18秒前
充电宝应助628采纳,获得10
18秒前
19秒前
cc发布了新的文献求助10
20秒前
文艺代丝发布了新的文献求助10
23秒前
23秒前
顾矜应助captainHc采纳,获得30
24秒前
Rooster发布了新的文献求助10
25秒前
28秒前
高高的新烟完成签到 ,获得积分10
30秒前
rocky15应助harry采纳,获得10
31秒前
思源应助阿七采纳,获得10
31秒前
彭于晏应助科研小白采纳,获得10
31秒前
32秒前
32秒前
34秒前
35秒前
靓丽的如南完成签到,获得积分10
35秒前
暴躁的黎云完成签到,获得积分10
37秒前
吴晨曦发布了新的文献求助10
37秒前
cctv18应助yqyqyq采纳,获得30
38秒前
fryeia发布了新的文献求助10
39秒前
埮埮完成签到,获得积分10
39秒前
40秒前
riqiu发布了新的文献求助10
41秒前
高分求助中
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Python Programming for Linguistics and Digital Humanities: Applications for Text-Focused Fields 500
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
行動データの計算論モデリング 強化学習モデルを例として 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2547837
求助须知:如何正确求助?哪些是违规求助? 2176358
关于积分的说明 5604129
捐赠科研通 1897190
什么是DOI,文献DOI怎么找? 946694
版权声明 565412
科研通“疑难数据库(出版商)”最低求助积分说明 503899